Adverse drug reactions & their risk factors among Indian ambulatory elderly patients

Indian Journal of Medical Research

Volumn 136, Issue 3, 2012, Pages 404-410

  Mandavi, ^a   D'Cruz, Sanjay ^b   Sachdev, Atul ^b   Tiwari, Pramil ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

ADRs; Ambulatory elderly patient; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; AMIODARONE; AMITRIPTYLINE; AMLODIPINE; ATORVASTATIN; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXOFYLLINE; GABAPENTIN; GATIFLOXACIN; GLUCOSAMINE; IMIPRAMINE; INSULIN; ISOSORBIDE MONONITRATE; METHOTREXATE; PHENYTOIN; PIOGLITAZONE; PRAZOSIN; PREDNISOLONE; ROSUVASTATIN; SIMVASTATIN; THEOPHYLLINE; THYROXINE; TORASEMIDE; UNINDEXED DRUG; WARFARIN;

ADULT; ADVERSE DRUG REACTION; AGE; AGED; AMBULATORY CARE; ARTICLE; ATAXIA; BLEEDING; BLURRED VISION; BRADYCARDIA; CONTROLLED STUDY; COUGHING; DAYTIME SOMNOLENCE; DEPENDENT PERSONALITY DISORDER; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG SURVEILLANCE PROGRAM; DYSTONIA; ECZEMA; FALLING; FEMALE; GASTRITIS; GERIATRIC PATIENT; HEADACHE; HEART ATRIUM FIBRILLATION; HEPATITIS; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOKALEMIA; HYPOTENSION; HYPOVOLEMIA; INCONTINENCE; INDIA; KIDNEY FAILURE; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MODIFIED HARTWIGS CRITERIA; MODIFIED SCHUMOCK AND THORNTONS CRITERIA; MOUTH ULCER; MYOPATHY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NARANJOS PROBABILITY SCALE; PATIENT MONITORING; PERIPHERAL EDEMA; PRESCRIPTION; PROSPECTIVE STUDY; PROTHROMBIN TIME; RISK FACTOR; SEX DIFFERENCE; SIDE EFFECT; SINUSITIS; SKIN MANIFESTATION; TACHYCARDIA; TEACHING HOSPITAL; THROMBOCYTOPENIA; THYROTOXICOSIS; TREATMENT DURATION; VERTIGO; XEROSIS;

AGED; DRUG TOXICITY; FEMALE; HUMANS; INDIA; LOGISTIC MODELS; MALE; PHARMACEUTICAL PREPARATIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84867144776     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Zhang M, Holman CDJ, Preen DB, Brameld K. Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. Br J Clin Pharmacol 2007; 63: 163-70.
2. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes. PLoS ONE 2009; 4: e4439.4.
3. Hamilton HJ, Gallagher PF, O'Mohony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatrics 2009; 9:
4. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006; 296: 1858-66.
5. Parthasarathi AG, Ramesh M, Guido S, Basavanagowdappa H. Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals. J Postgrad Med 2011; 57: 189-95.
6. Carbonin P, Pahor M, Bernabei R, Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients J Am Geriatr Soc 1991; 39: 1093-9.
7. th ed. New York: McGraw-Hill; 2002. p. 79-89.
8. Mandavi, D'Cruz S, Sachdev A, Tiwari P. Prevalence and predictors of inappropriate drug use among older people: results from an Indian public outpatient setting. J Pharmaceutical Health Services Res 2011; 2: 29-34.
9. Tulner LR, Kuper IM, Frankfort SV, van Campen JP, Koks CH, Brandjes DP, et al. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions. Am J Geriatr Pharmacother 2009; 7: 93-104.
10. Amrita P, Singh SP. Status of spontaneous reporting of adverse drug reaction by physicians in Delhi. Indian J Pharm Pract 2011; 4: 29-36.
11. th revision (ICD-10). Geneva: WHO; 2010.
12. WHO Collaborating Centre for Drug Statistic Methodology. Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Dose. Geneva: WHO; 2003.
13. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255-9.
14. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
15. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992; 27: 538.
16. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992; 49: 2229-32.
17. Schneider JK, Mion LC, Frengley JD. Adverse drug reactions in an elderly outpatient population. Am J Hosp Pharm 1992; 49: 90-6.
18. Hartholt KA, van der Velde N, Looman CW, Panneman MJ, van Beeck EF, Patka P, et al. Adverse drug reactions related hospital admissions in persons aged 60 years and over, The Netherlands, 1981-2007: less rapid increase, different drugs. PLoS ONE 2010; 5: e13977.
19. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199-205.
20. Pepine CJ, Cooper-DeHoff RM, Weiss RJ, Koren M, Bittar N, Thadani U, et al. Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. Am J Cardiol 2003; 91: 274-9.
21. Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough ACCP Evidence-Based Clinical Practice Guidelines. Chest 2006; 129: 169S-73S.
22. Dykewicz MS. From current opinion in allergy and clinical immunology cough and angioedema from angiotensin-converting enzyme inhibitors: New insights into mechanisms and management. Curr Opin Allergy Clin Immunol 2004; 4: 267-70.
23. Brvar M, Fokter N, Bunc M, Mozina M. The frequency of adverse drug reaction related admissions according to methodof detection, admission urgency and medical department specialty. BMC Clin Pharmacol 2009; 9: 8.
24. Rupawala AH, Kshirsagar NA, Gogtay NJ. A retrospective analysis of adverse events in the elderly in a tertiary referral center in Mumbai (Bombay), India. Indian J Med Sci 2009; 63: 167-73.
25. Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res 2006; 54: 226-33.
26. Suh DC, Woodall BS, Shin SK, Hermes-De-Santis ER. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother 2000; 34: 1373-9.
27. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med 2003; 348: 1556-64.
28. Zhang M, Holman CDJ, Price SD, Sanfilippo FM, Preen DB, Bulsara MK. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ 2008; 337: 2752.
29. Rademaker M. Do women have more adverse drug reactions Am J Clin Dermatol 2006; 2: 349-51.
30. Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, Car J, et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005. BMC Clin Pharmacol 2007; 7: 9.